Walleye Trading
FLNA

Walleye Trading’s Filana Therapeutics FLNA Stock Holding History

Walleye Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.4K Buy
20,968
+11,790
+128% +$24.3K ﹤0.01% 3759
2025
Q4 		$18.2K Sell
9,178
-26,475
-74% -$84.8K ﹤0.01% 4115
2025
Q3 		$104K Buy
35,653
+16,484
+86% +$37.9K ﹤0.01% 3700
2025
Q2 		$34.7K Sell
19,169
-23,726
-55% -$42.2K ﹤0.01% 3893
2025
Q1 		$64.3K Buy
+42,895
New +$108K ﹤0.01% 3543
2024
Q3 		– Sell
-3,985
Closed -$91.8K – 4522
2024
Q2 		$49.2K Buy
+3,985
New +$84K ﹤0.01% 3593
2023
Q3 		– Sell
-27,009
Closed -$535K – 5315
2023
Q2 		$662K Buy
+27,009
New +$650K ﹤0.01% 2527
2021
Q2 		– Sell
-348
Closed -$18.6K – 5498
2021
Q1 		$16K Buy
+348
New +$13.7K ﹤0.01% 4588
2016
Q3 		– Sell
-214
Closed -$3K – 5349
2016
Q2 		$3K Buy
+214
New +$3.39K ﹤0.01% 5075

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Walleye Trading's FLNA Position: Q1 2026 in Review

Walleye Trading increased its Filana Therapeutics (FLNA) stake by 128% in Q1 2026, buying an estimated $24.3K and bringing the position to 20,968 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3759.

Walleye Trading first reported a position in FLNA in Q2 2016 and has held it in 9 quarters since. The position peaked at $662K in Q2 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Walleye Trading held 20,968 shares of Filana Therapeutics worth $35.4K as of Q1 2026.
  • Walleye Trading bought 11,790 Filana Therapeutics shares in Q1 2026, an estimated $24.3K.
  • Filana Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3759 holding.
  • Walleye Trading first reported a position in Filana Therapeutics in Q2 2016 and has held it in 9 quarters since.
  • Walleye Trading's Filana Therapeutics position peaked at $662K in Q2 2023.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.